Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexagene Holdings Inc LXXGQ

Healthcare Medical Devices
Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.


GREY:LXXGQ - Post by User

Lexagene Holdings Inc > New 5 minutes test for COVID-19 by Abott
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(4)
•••
Comment by 007daveon Mar 30, 2020 11:01am
72 Views
Post# 30859852

RE:RE:RE:New 5 minutes test for COVID-19 by Abott

RE:RE:RE:New 5 minutes test for COVID-19 by AbottGreat information again Mr Sanchez and I'm pretty sure the long term holders believe in Dr Regan and the LX2 capabilities big BUT here is Lexagene seems to be slow to the party and in recent new releases the information seems vague. I've said it before just be clear and concise. " Yes Lexagene has developed not is developing and give us and the market a start date for manufacturing. Also be specific on a timeline for bringing a commercial machine to market. Is it the summer or fall seem to be getting different times for release. Finally let loose Mr Armstrong. Assure the shareholders, because some big shareholder is selling this morning.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities